Technical Analysis for CARA - Cara Therapeutics, Inc.

Grade Last Price % Change Price Change
grade D 14.86 6.68% 0.93
CARA closed up 6.68 percent on Tuesday, October 20, 2020, on 2.24 times normal volume. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Up Up
Historical CARA trend table...

Date Alert Name Type % Chg
Crossed Above 50 DMA Bullish 0.00%
Pocket Pivot Bullish Swing Setup 0.00%
Above Upper BB Strength 0.00%
Upper Bollinger Band Touch Strength 0.00%
Crossed Above 20 DMA Bullish 6.14%
Wide Range Bar Range Expansion 6.14%
Down 3 Days in a Row Weakness 13.61%
Fell Below 20 DMA Bearish 10.98%
20 DMA Support Bullish 8.31%
NR7 Range Contraction 8.31%
Older End-of-Day Gignals for CARA ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Possible Pocket Pivot about 6 hours ago
60 Minute Opening Range Breakdown about 7 hours ago
Gap Up Partially Closed about 8 hours ago
Upper Bollinger Band Resistance about 8 hours ago
50 DMA Resistance about 8 hours ago
View Earlier Intraday Alerts

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Cara Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics to treat pain. Its products include intravenous CR845 that has completed Phase II clinical trials for the treatment of acute postoperative pain in adult patients; Oral CR845, which is in Phase I clinical trials to treat acute and chronic pain; and CR701 that is in preclinical trials for treating neuropathic and inflammatory pain. The company was founded in 2004 and is based in Shelton, Connecticut.
Chemistry Biopharmaceutical Health Pain Clinical Trial Piperidines Amines Mesoblast

Is CARA a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 26.67
52 Week Low 8.88
Average Volume 402,853
200-Day Moving Average 15.41
50-Day Moving Average 14.76
20-Day Moving Average 13.49
10-Day Moving Average 13.90
Average True Range 0.63
ADX 23.17
+DI 31.49
-DI 20.59
Chandelier Exit (Long, 3 ATRs ) 13.34
Chandelier Exit (Short, 3 ATRs ) 14.19
Upper Bollinger Band 14.75
Lower Bollinger Band 12.24
Percent B (%b) 1.04
BandWidth 18.65
MACD Line -0.16
MACD Signal Line -0.36
MACD Histogram 0.1969
Fundamentals Value
Market Cap 696.74 Million
Num Shares 46.9 Million
EPS -2.17
Price-to-Earnings (P/E) Ratio -6.86
Price-to-Sales 26.91
Price-to-Book 4.65
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 16.50
Resistance 3 (R3) 16.44 15.83 16.22
Resistance 2 (R2) 15.83 15.42 15.86 16.13
Resistance 1 (R1) 15.35 15.16 15.05 15.41 16.04
Pivot Point 14.74 14.74 14.59 14.77 14.74
Support 1 (S1) 14.26 14.33 13.96 14.32 13.68
Support 2 (S2) 13.65 14.07 13.68 13.59
Support 3 (S3) 13.17 13.65 13.50
Support 4 (S4) 13.23